Medanta to start IPD services at Patna hospital
Update: 01 Nov 2021 14:27 STI
Patna (Bihar) [India], Nov 1 (ANI / NewsView): Global Health Limited, one of the largest private multi-specialty tertiary care providers operating in the northern and eastern regions of India with key specialties in cardiology and science Cardiac, Neuroscience, Oncology, Digestive and Hepatobiliary Sciences, Orthopedics, Liver Transplantation, Kidney and Urology (Source: Based on “An Assessment of the Healthcare Delivery Market in India” report, September 2021 prepared and published by CRISIL Limited) today announced the start of its Hospitalization (IPD) at Jay Prabha Medanta Super Specialty Hospital in Patna.
In keeping with its commitment to clinical excellence and patient care, Jay Prabha Medanta Super Specialty Hospital in Patna, under its “Medanta” brand, will complement the flagship Medanta Gurugram Hospital in the National Capital Region of New Delhi .
Commenting on the occasion, Chief Minister Nitish Kumar said: “I am delighted to dedicate quality health care to the citizens of Bihar through the Jay Prabha Medanta Super Specialist Hospital. The hospital will offer technologically advanced treatment and will be a new benchmark in health care in the state. . “
The hospital will offer a multidisciplinary, physician-led approach to treatment in cardiology and cardiac surgery, neurology and neurosurgery, gastroenterology and hepatology, gastrointestinal surgery, urology and nephrology, orthopedics and joint replacement, gynecology, radiology, respiratory medicine , internal medicine, diabetes and endocrinology, dental sciences, intensive care and anesthesia and radiology.
Jay Prabha Medanta Super Specialty Hospital is approximately 1.0 million square feet in gross area, spans 7 acres, and is designed to accommodate 500 beds, 112 intensive care beds and 14 operating theaters. It is expected to have 300 beds installed by fiscal 2022.
Dr Naresh Trehan, President and CEO of Medanta, said: “At Medanta, we strive to provide world-class healthcare by creating institutes of excellence that integrate healthcare, education and research while providing affordable medical services to patients. We also equip our hospitals with advanced medical technology and equipment and diagnostic instruments with the aim of providing our patients with accurate diagnoses and effective treatments. from northeast India, parts of Jharkhand and Nepal. “
Founded by Dr Naresh Trehan, a world renowned cardiovascular and cardiothoracic surgeon who received the prestigious Padma Bhushan and the Padma Shri, the third and fourth highest civilian awards in India and the BC Roy award in recognition of his distinguished contribution to medicine, Global Health Limited (the “Company”) is one of the largest private providers of multi-specialty tertiary care operating in the northern and eastern regions of India, with key specialties in cardiology and cardiac sciences, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, kidney and urology, according to the report titled “An Assessment of the Healthcare Delivery Market in India, September 2021” by CRISIL Limited.
Under the “Medanta” brand, the Company has a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow). Covering an area of 3.7 million square feet, its operational hospitals have 2,176 beds installed as of March 31, 2021. It is now starting its inpatient operations in Patna and also has a hospital planned for development in Noida. As of March 31, 2021, the Company provided health services in more than 30 medical specialties and hired more than 1,100 physicians led by highly experienced department heads.
The Company’s facilities have received national and international accreditations, including NABH accreditation for Gurugram Hospital and Blood Bank. Gurugram Hospital has been ranked the best private hospital in India for two consecutive years in 2020 and 2021, and was the only Indian private hospital to feature in Newsweek’s list of the world’s top 200 hospitals in 2021.
Gurugram Hospital was also included in the list of the world’s best specialist hospitals in cardiology in 2021, and in cardiology and neurology in the 2022 rankings published by Newsweek.
medanta.org; facebook.com/medanta; twitter.com/medanta; instagram.com/medanta.
Some of the information in this letter is from the report titled “An Assessment of the Healthcare Delivery Market in India, September 2021” by CRISIL Limited, which is subject to the following disclaimer:
CRISIL Research, a division of CRISIL Limited (CRISIL) has exercised diligence and caution in preparing this report (Report) on the basis of Information obtained by CRISIL from sources it considers reliable (Data).
CRISIL does not guarantee the accuracy, adequacy or completeness of any element contained or mentioned in the Report. This report is not a recommendation to invest / disinvest in any entity covered by the report and no part of this report should be construed as expert opinion or investment advice or any form of investment banking. within the meaning of any law or regulation. CRISIL declares in particular that it assumes no responsibility towards the subscribers / users / issuers / distributors of this Report.
Without limiting the generality of the foregoing, nothing in the report should be interpreted as providing or intending to provide services in jurisdictions where CRISIL does not have the necessary authorization and / or registration to conduct its business. commercial activities in this regard. Global Health Limited will be responsible for ensuring compliance and the consequences of non-compliance for the use of the report or any part of it outside of India.
CRISIL Research operates independently and does not have access to information obtained by CRISIL Ratings Limited / CRISIL Risk and Infrastructure Solutions Ltd (CRIS), which may, in their regular operations, obtain information of a confidential nature. The opinions expressed in this report are those of CRISIL Research and not of CRISIL Ratings Limited / CRIS. No part of this report may be published / reproduced in any form without the prior written approval of CRISIL.
This story is provided by NewsView. ANI will not be responsible for the content of this article in any way. (ANI / NewsView)